» Articles » PMID: 352258

New in Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity

Overview
Specialty Pharmacology
Date 1978 Apr 1
PMID 352258
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

A new apparatus is described which serves to investigate the in vitro antibacterial activity of antibiotics as a function of different concentration time curves. The apparatus can be adjusted to simulate the biexponential serum level curves observed in vivo after oral or intramuscular administration. Preliminary studies were carried out with a cephalosporin derivative, cefazolin, against Escherichia coli and Klebsiella sp. strains simulating initial concentrations of 5, 10, and 20 mug/ml that decreased exponentially with half-lives of 30, 60, and 120 min. Surviving cells were counted at 1-h intervals for 10 h. In all the situations tested there was an initial phase of rapid bactericidal activity followed by a phase of bacteriostatic activity, whose length depended on the drug elimination rate but was relatively independent of the initial concentrations. Bacterial regrowth occurred when the antibiotic concentration fell below the minimum inhibitory concentration of the drug against the strains tested. The antibacterial activity of cefazolin, cephacetrile, and cephradine against E. coli and Klebsiella strains was also investigated, in a medium containing 4% human albumin, simulating the serum level curves observed in humans after an intramuscular dose of 1 g. The results obtained suggest that, for cephalosporins, a longer half-life might be more useful than higher peak levels.

Citing Articles

Adaptation of an one-compartment pharmacodynamic chemostat for testing efficacy of ceftazidime against outside a BSL3 facility.

Zamri H, Mohd Ali M, Shaari A, Mohd Mazalan N, Ahmad N, Nor Amdan N MethodsX. 2025; 14:103167.

PMID: 39897649 PMC: 11782592. DOI: 10.1016/j.mex.2025.103167.


Dynamic PK/PD Infection Models for the Development and Optimisation of Antimicrobial Regimens: A Narrative Review.

Wale Y, Roberts J, Sime F Antibiotics (Basel). 2025; 13(12.

PMID: 39766591 PMC: 11672834. DOI: 10.3390/antibiotics13121201.


Applications of the hollow-fibre infection model (HFIM) in viral infection studies.

Kembou-Ringert J, Readman J, Smith C, Breuer J, Standing J J Antimicrob Chemother. 2022; 78(1):8-20.

PMID: 36411255 PMC: 9780528. DOI: 10.1093/jac/dkac394.


The Application of Hollow Fiber Cartridge in Biomedicine.

Hou Y, Mi K, Sun L, Zhou K, Wang L, Zhang L Pharmaceutics. 2022; 14(7).

PMID: 35890380 PMC: 9316653. DOI: 10.3390/pharmaceutics14071485.


A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.

Singh D, Deosarkar S, Cadogan E, Flemington V, Bray A, Zhang J PLoS Biol. 2022; 20(5):e3001624.

PMID: 35617197 PMC: 9135222. DOI: 10.1371/journal.pbio.3001624.


References
1.
ROWE E, MOROZOWICH W . A simple dilution analog computer for simulation of drug distribution processes. J Pharm Sci. 1969; 58(11):1375-8. DOI: 10.1002/jps.2600581117. View

2.
STEIGBIGEL N, McCall C, REED C, FINLAND M . Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci. 1967; 145(2):224-36. DOI: 10.1111/j.1749-6632.1967.tb50221.x. View

3.
Rattie E, RAVIN L . Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans. Antimicrob Agents Chemother. 1975; 7(5):606-13. PMC: 429190. DOI: 10.1128/AAC.7.5.606. View

4.
BUCK R, Leitner F, PRICE K . 7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid. Antimicrob Agents Chemother. 1972; 1(1):67-72. PMC: 444167. DOI: 10.1128/AAC.1.1.67. View

5.
Greenwood D, Ogrady F . Trimodal response of Escherichia coli and Proteus mirabilis to penicillins. Nature. 1970; 228(5270):457-8. DOI: 10.1038/228457a0. View